Getting cytisine licensed for use world-wide: a call to action

Affiliations

• ¹ National Institute for Health Innovation and Centre for Addiction Research, School of Population Health, University of Auckland, Auckland, New Zealand. n.walker@auckland.ac.nz.
• ² National Institute for Health Innovation, School of Population Health, University of Auckland, Auckland, New Zealand.
• ³ School of Pharmacy, University of Auckland, Auckland, New Zealand.
• ⁴ Queen Mary University of London, London, UK.
• ⁵ Department of Pharmacology, Centre for Innovative Research for Medical and Natural Sciences, University of Rzeszów, Rzeszów, Poland.
• ⁶ UK Centre for Tobacco Control Studies, University of Nottingham, Nottingham, UK.
• ⁷ Faculty of Medicine, University of Geneva, Geneva, Switzerland.
• ⁸ Department of Health Sciences, University of York, York, UK.
• ⁹ National Drug and Alcohol, Research Centre, University of New South Wales, Sydney, Australia.
• ¹⁰ Department of Neuroscience, Medical School, Fundação do ABC, Santo André, Brazil.
• ¹¹ Departments of Family and Community Medicine, Psychiatry and Public Health Sciences, University of Toronto, Toronto, Canada.
• ¹² School of Pharmacy and Centre for Addiction Research, University of Auckland, Auckland, New Zealand.
• ¹³ Harvard Medical School, Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, USA.